{
    "doi": "https://doi.org/10.1182/blood-2021-152907",
    "article_title": "Response to BNT162b2 Sars-Cov-2 Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant ",
    "article_date": "November 5, 2021",
    "session_type": "722.Allogeneic Transplantation: Acute and Chronic GVHD, Immune Reconstitution",
    "abstract_text": "Recipients of allogeneic hematopoietic stem cell transplant (HSCT) have been excluded from clinical trials of SARS-CoV-2 messenger RNA (mRNA) vaccines; however, since these patients are at higher risk of severe complications following infection, they have been given high priority in vaccination campaigns worldwide. In this prospective observational study, we evaluated the immunogenicity of two BNT162b2 (Pfizer-BioNTech) vaccine doses in allogeneic HSCT recipients compared to healthy controls. IgG antibodies to the receptor-binding domain (RBD) of the S1 subunit of the spike protein of SARS-CoV-2 were analyzed by SARS-CoV-2 IgG II Quant (Abbott, Ireland). The cutoff value of the test used in this study is 7.1 BAU/mL (Binding Antibody Unit/mL) and the results greater than 7.1 indicate that seroconversion has occurred, as recommended by the manufacturer. Peripheral blood samples were collected for immunological analysis at three timepoints: pre-vaccine baseline (w0, before the first BNT162b2 dose), week 3 (w3, before the second vaccine dose) and week 5 (w5, 2 weeks following the second dose). Patients older than 18 years who received BNT162b2 vaccine following an HSCT at seven Italian centers were included in the study. Enrolled patients received two successive doses (at 3-week interval) at a median of 15 months (range 2-141) after HSCT. Twenty-nine age-matched health care workers who were vaccinated with BNT162b2 were recruited as the control group. Among the 34 patients evaluable for serological response, three patients were excluded from the analysis as the baseline serology demonstrated previous natural SARS-CoV-2 infection. On w3, after the first vaccine dose 7/31 (23%) patients developed anti-S IgG antibodies as compared to 28/29 (97%) controls (p12 months, p200/mm3, p=0.01), and CD4+CD45RA+ T naive cell count (>100/ mm3, p<0.01) were significantly associated with antibody response after the first vaccine dose. On w5, after the second vaccine dose, 24/31 (77%) of the patients showed antibody response, as compared to 99% of healthy controls (p<0.01); in fact, 71% of non-responders to the first dose developed IgG antibodies after vaccine boost (Figure 1). Median antibody titer after second dose was 350 BAU/ml (0-21.731). In univariate analysis, no significant association was found between patient characteristics and immunogenicity after vaccine boost. Adverse events were rare and modest. Nine percent of the patients reported mild local reactions after vaccine administration, including pain at the injection site and less commonly local erythema, local lymphadenopathy, or swelling; 35% of patients reported systemic adverse events, and all were mild. The most frequently reported systemic reactions included weakness (15%), headache (9%), and diarrhea (3%). In conclusion, in recipients of HSCT, a single dose of the BNT162b2 SARS-CoV-2 vaccine yielded poor efficacy, while immunogenicity increased significantly after vaccine boost at day 21 after the first dose. Patients who received vaccines beyond one year after transplant were more likely to mount anti-S IgG antibodies, which could be due to a broader immune reconstitution, as we observed an enhanced response to single BNT162b2 vaccine dose in patients with higher CD4+ T cell and particularly CD4+CD45RA+ na\u00efve T cell counts. Figure 1 View large Download slide Figure 1 View large Download slide  Close modal Disclosures Kordasti:  Alexion: Honoraria; Celgene: Research Funding; Beckman Coulter: Honoraria; Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding. Pane:  AbbVie; Amgen; Novartis: Other: Travel, accommodation, expenses; AbbVie; Amgen; Novartis, GSK, Incyte: Speakers Bureau; Novartis Pharma SAS;: Research Funding; AbbVie; Amgen; Novartis, GSK , Incyte: Consultancy.",
    "author_names": [
        "Francesco Saraceni",
        "Alessandro Fiorentini",
        "Sonia Mor\u00e8",
        "Selene Guerzoni",
        "Bruna Puglisi",
        "Benedetta Corvaro",
        "Sara Caucci",
        "Stefano Menzo",
        "Andrea Costantini",
        "Luca Butini",
        "Nadia Viola",
        "Ilaria Scortechini",
        "Giorgia Mancini",
        "Maria Vittoria Dubbini",
        "Irene Federici",
        "Shahram Kordasti",
        "Massimo Offidani",
        "Francesca Patriarca",
        "Marta Lisa Battista",
        "Martina Chiarucci",
        "Giuseppe Visani",
        "Sadia Falcioni",
        "Piero Galieni",
        "Annalisa Natale",
        "Doriana Vaddinelli",
        "Stella Santarone",
        "Fabrizia Colasante",
        "Angelo Michele Carella",
        "Giorgia Battipaglia",
        "Fabrizio Pane",
        "Attilio Olivieri"
    ],
    "author_dict_list": [
        {
            "author_name": "Francesco Saraceni",
            "author_affiliations": [
                "Hematology and Stem Cell Transplant, Ancona University Hospital, Ancona, Italy"
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Alessandro Fiorentini",
            "author_affiliations": [
                "Ospedali Riuniti Ancona, Ancona, Italy"
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sonia Mor\u00e8",
            "author_affiliations": [
                "Ospedali Riuniti Ancona, Ancona, Italy"
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Selene Guerzoni",
            "author_affiliations": [
                "Ospedali Riuniti Ancona, Ancona, Italy"
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Bruna Puglisi",
            "author_affiliations": [
                "Ospedali Riuniti Ancona, Ancona, Italy"
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Benedetta Corvaro",
            "author_affiliations": [
                "Ospedali Riuniti Ancona, Ancona, Italy"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sara Caucci",
            "author_affiliations": [
                "Ospedali Riuniti Ancona, Ancona, Italy"
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stefano Menzo",
            "author_affiliations": [
                "Ospedali Riuniti Ancona, Ancona, Italy"
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Andrea Costantini",
            "author_affiliations": [
                "Ospedali Riuniti Ancona, Ancona, Italy"
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Luca Butini",
            "author_affiliations": [
                "Ospedali Riuniti Ancona, Ancona, Italy"
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nadia Viola",
            "author_affiliations": [
                "Ospedali Riuniti Ancona, Ancona, Italy"
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ilaria Scortechini",
            "author_affiliations": [
                "Clinica di Ematologia Ospedali Riuniti, Ancona, Italy, Ancona, Italy"
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giorgia Mancini",
            "author_affiliations": [
                "Ospedali Riuniti Ancona, Ancona, ITA"
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Vittoria Dubbini",
            "author_affiliations": [
                "Ospedali Riuniti Ancona, Ancona, Italy"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Irene Federici",
            "author_affiliations": [
                "Ospedali Riuniti Ancona, Ancona, ITA"
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Shahram Kordasti",
            "author_affiliations": [
                "Systems Cancer Immunology, Comprehensive Cancer Centre, King's College London, London, United Kingdom"
            ],
            "author_rank": 16,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Massimo Offidani",
            "author_affiliations": [
                "Hematology Department, University of Ancona, Ancona, Italy"
            ],
            "author_rank": 17,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francesca Patriarca",
            "author_affiliations": [
                "Clinical Hematology and Bone Marrow Transplant Centre, S Maria della Misericordia University Hospital, DAME, University of Udine, Udine, Italy"
            ],
            "author_rank": 18,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marta Lisa Battista",
            "author_affiliations": [
                "ASUI Udine S.M. della Misericordia P.le S.M. della Misericordia 15 Clinica Emato, Udine, ITA"
            ],
            "author_rank": 19,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Martina Chiarucci",
            "author_affiliations": [
                "Ospedali Riuniti Marche Nord, Pesaro, Italy"
            ],
            "author_rank": 20,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giuseppe Visani",
            "author_affiliations": [
                "Hematology, Ospedale San Salvatore, Pesaro, Italy"
            ],
            "author_rank": 21,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sadia Falcioni",
            "author_affiliations": [
                "Haematology Unit Ascoli Piceno, Ascoli Piceno, ITA"
            ],
            "author_rank": 22,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Piero Galieni",
            "author_affiliations": [
                "UOC Ematologia e Terapia Cellulare, Ospedale \"C. e G. Mazzoni\", Ascoli Piceno, Italy"
            ],
            "author_rank": 23,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Annalisa Natale",
            "author_affiliations": [
                "Department of Hematology, Clinical Hematology, Pescara, ITA"
            ],
            "author_rank": 24,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Doriana Vaddinelli",
            "author_affiliations": [
                "Ospedale Civile S. Spirito Pescara, Pescara, Italy"
            ],
            "author_rank": 25,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stella Santarone",
            "author_affiliations": [
                "Centro Trapianti Midollo Osseo, Pescara, ITA"
            ],
            "author_rank": 26,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fabrizia Colasante",
            "author_affiliations": [
                "Ospedale \"Casa Sollievo della Sofferenza\" IRCCS, San Giovanni Rotondo, Italy"
            ],
            "author_rank": 27,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Angelo Michele Carella",
            "author_affiliations": [
                "DEPARTMENT OF HEMATO-ONCOLOGY, STEM CELL TRANSPLANT UNIT, IRCCS, Casa Sollievo Della Sofferenza, San Giovanni Rotondo, ITA"
            ],
            "author_rank": 28,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giorgia Battipaglia",
            "author_affiliations": [
                "Hematology Department Federico II University, Naples, Italy"
            ],
            "author_rank": 29,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fabrizio Pane",
            "author_affiliations": [
                "Dipartimento Medicina Clin e Chirurgia, UOC Ematologia e Trapianti di Midollo, Azienda Ospedaliera Universita Federico II, Napoli, Italy"
            ],
            "author_rank": 30,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Attilio Olivieri",
            "author_affiliations": [
                "Ospedali Riuniti di Ancona, Clinic of Hematology, Ancona, Italy"
            ],
            "author_rank": 31,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-06-21T15:40:57",
    "is_scraped": "1"
}